References
- Russell IJ, Orr MD, Littmann B, Vipraio GA, Alboukrek D, Michalek JE, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994;37:1593–1601.
- Vaeroy H, Helle R, Forre 0, Kass E, Terenius L. Cerebrospinal fluid levels of beta-endorphin in patients with fibromyalgia (fibrositis syndrome) J Rheumatol 1988;15: 1804— 1806.
- Samborski W, Stratz T, Schochat T, Mennet P, Muller W. Biochemical changes in fibromyalgia. Z Rheumatol 1996; 55:168–73.
- Saria A, Javorsky F, Humpel C, Gamse R. 5-HT3 receptor antagonists inhibit sensory neuropeptide release from the spinal cord. Neuroreport 1990;1:104–6.
- Russell U. Substance P and fibromyalgia. J Musculoske Pain 1998;6:29— 35.
- Littlejohn GO, Weinstein C, Halme DR. Increased neurogenic inflammation in fibrositis syndrome. J. Rheumatol 1987; 14:1022–5.
- Salemi S, Rethage J, Wollina U, Muchel BA, Gay RE, Gay ST, Sprott H. Detection of Interleukin-113 (IL-, Interleukin-6) and tumor necrosis factor-a in skin of patients with fibro-myalgia. J Rheumatol 2003;30: 148–50.
- Enestrom S, Bengtsson A, Trodin T. Dermal IgG deposits and increase of mast cells in patients with fibromyalgia relevent findings of epiphenomena? Scand J RheumatoJ 1997; 26:308–131.
- Egle UT, Nickel R, Schwab R, Hoffmann SO. Die somatoforme Schmerzstörung. Dtsch. Arzteblatt 2000;97: 1469— 73.
- Muller W, Stratz T. 5-HT3-receptor-antagonists in therapy of rheumatic diseases. Z Rheumatol 2003;62:39–41.
- Wolfe F, Smythe HA, Yunus MB, Bennet RM, Bombardier C, Goldenberg DL, et al. Criteria for the classification of fibromyalgia, Report of the multicenter criteria committee. Arthritis Rheum 1990;33:160–72.
- Farber L, Stratz T, Bruckle W, Spath M, Pongratz D, Lautenschlager J, et al. Efficacy and tolerability of tropise-tron in primary fibromyalgia, a highly selective and compe-titive 5-HT3- receptor antagonist. Scand J Rheumatol 2000; 29 Suppl 113:49–54.
- Spath M, Stratz T, Schmalisch P, Fischer P, Haslinger A, Schwarz M, et al. Substance P in selectal muscle of pati-ents with fibromyalgia syndrome. J Musculoske Pain 1998; 6 Suppl 2:78.